Lurasidone for Pediatric Bipolar Disorder Linked to Decreased Hospitalization Risk
Compared with olanzapine and aripiprazole, lurasidone was linked with lower risk for all-cause and psychiatric hospitalization in pediatric patients.
All articles by Natasha Priya Dyal, MD
Patient Groups Urge Court of Appeals to Prioritize Patient Protections
Patient groups have issued a joint statement today to urge the Fifth Circuit Court of Appeals to prioritize patient protections as it presides over arguments in the case Texas v United States.
Next post in Practice Management
